308 related articles for article (PubMed ID: 27676456)
1. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
[TBL] [Abstract][Full Text] [Related]
2. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
3. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
[TBL] [Abstract][Full Text] [Related]
4. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.
Sjökvist Ottsjö L; Flach CF; Nilsson S; Malefyt Rde W; Walduck AK; Raghavan S
PLoS One; 2015; 10(7):e0131444. PubMed ID: 26168305
[TBL] [Abstract][Full Text] [Related]
5. The frequency of circulating integrin α4β7
Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach.
Raghavan S; Ostberg AK; Flach CF; Ekman A; Blomquist M; Czerkinsky C; Holmgren J
Infect Immun; 2010 Oct; 78(10):4251-60. PubMed ID: 20696831
[TBL] [Abstract][Full Text] [Related]
7. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.
Leach S; Clements JD; Kaim J; Lundgren A
PLoS One; 2012; 7(12):e51718. PubMed ID: 23284753
[TBL] [Abstract][Full Text] [Related]
8. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
[TBL] [Abstract][Full Text] [Related]
10. Oral immunization of BALB/c mice with recombinant Helicobacter pylori antigens and double mutant heat-labile toxin (dmLT) induces prophylactic protective immunity against H. pylori infection.
Zhong Y; Chen J; Liu Y; Zhang Y; Tang C; Wang X; Wang P; Chen W; Wei B; Liu M
Microb Pathog; 2020 Aug; 145():104229. PubMed ID: 32353579
[TBL] [Abstract][Full Text] [Related]
11. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
12. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
14. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
[TBL] [Abstract][Full Text] [Related]
15. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
16. Persistence of mucosal and systemic immune responses following sublingual immunization.
Negri DR; Riccomi A; Pinto D; Vendetti S; Rossi A; Cicconi R; Ruggiero P; Del Giudice G; De Magistris MT
Vaccine; 2010 Jun; 28(25):4175-80. PubMed ID: 20412876
[TBL] [Abstract][Full Text] [Related]
17. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.
Marchetti M; Rossi M; Giannelli V; Giuliani MM; Pizza M; Censini S; Covacci A; Massari P; Pagliaccia C; Manetti R; Telford JL; Douce G; Dougan G; Rappuoli R; Ghiara P
Vaccine; 1998 Jan; 16(1):33-7. PubMed ID: 9607006
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
[TBL] [Abstract][Full Text] [Related]
19. The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof.
Lee S; Picking WL; Tzipori S
Microbes Infect; 2014 Sep; 16(9):796-803. PubMed ID: 25111827
[TBL] [Abstract][Full Text] [Related]
20. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
